Search Results 401-410 of 6650 for 청주청원

1. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

   Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...

2. Mayo Clinic Minute: Understanding and treating lymphoma Video Audio

   "The cancer in this case is the immune system. So, often, we're trying to get the immune system to fight against the cancer. But in this case, the challenge ...

3. Vascular Ulcer and Wound Healing Clinic in Minnesota - Overview

   Therapy to improve circulation; Edema reduction therapy; Wound debridement; Cellular or tissue-based products; Specific wound treatment product substitutes.

4. Publications

   Publications. Singh PG, Kilari S, Misra S. Vessel Wall Histologic Changes in a Porcine Model of Arteriovenous Fistula Stenosis Treated with Percutaneous ...

5. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...

6. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   Subjects will receive dabrafenib 150 mg twice daily (BID) in monotherapy treatment and dabrafenib 150 mg bid and trametinib 2 mg once daily in combination ...

7. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Akt inhibitor MK2206 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

8. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

10. Laryngology - Department of Otorhinolaryngology - Mayo Clinic Research

    Laryngology researchers in the Mayo Clinic Department of Otolaryngology — Head and Neck Surgery study voice, airway and swallowing disorders.